Geron reported $-3.64M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Amgen USD 2.08B 570M Mar/2026
Bio Techne USD 106.09M 34.87M Jun/2026
Cassava Sciences USD -10.81M 33.41M Sep/2025
Cytokinetics USD -206.03M 23M Mar/2026
Exelixis USD 262.68M 5.01M Jun/2026
Genmab DKK 295M 221M Jun/2026
Geron USD -3.64M 27.5M Mar/2026
Gilead Sciences USD -7.53B 10.11B Jun/2026
Incyte USD 751.51M 407.91M Jun/2026
MacroGenics USD -36.77M 21.84M Mar/2026
Novartis USD 4.27B 430M Jun/2026
Novavax USD 17.9M 220.94M Dec/2025